uniqureANGPTL3
$uniQure(QURE)$
COVID-19
$Arrowhead制药(ARWR)$
uniqureANGPTL3
$uniQure(QURE)$
Completed discovery and optimization work and advanced ARO-Lung2, Arrowhead’s investigational RNAi therapeutic being developed for the treatment of chronic obstructive pulmonary disorder (COPD), into IND-enabling studies with a planned CTA filing in the first half of 2021. A...
ARWR
$再生元制药(REGN)$ planning to have "hundreds of thousands of preventative doses available by the end of August 2020" for its REGN-COV2 antibody cocktail
$吉利德科学(GILD)$
Maury spoke with Dr. Kyle Hogarth of the Alpha One Antitrypsin Deficiency Clinical Resource Center at the University of Chicago. Dr. Hogarth's A1 Center is a Center of Excellence for A1 patients. Much of the call was focused around Arrowhead's ARO-AAT drug, with some ...
$DXCM: Dexcom beats by $0.29, beats on revs; suspends 2020 guidance
网页链接
$德康医疗(DXCM)$
$13Bn Blood Glucose Monitoring Devices Market Outlook, 2023 - Driven by the Phenomenal Sales Growth of New Revolutionary CGMs (Abbott's Freestyle Libre, Dexcom's G6 CGM)
网页链接
AACR 2020 preview – no Tigit, but plenty of novel mechanisms
网页链接
$Iovance(IOVA)$ $康方生物-B(09926)$
Announces AXS-05 Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial in Alzheimer’s Disease Agitation
$Axsome Therapeutics(AXSM)$
catalysts
$再生元制药(REGN)$
Blackstone, Alnylam enter into $2B financing collaboration for RNAi therapeutics
网页链接
$阿里拉姆制药(ALNY)$
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis
网页链接
$Arrowhead制药...
Chasing Arrowhead, onetime rivals Alnylam and Dicerna unite on liver disease
网页链接
$Arrowhead制药(ARWR)$ $阿里拉姆制药(ALNY)$ $Dicerna制药(DRNA)$
Joint makers report pandemic pain
网页链接
$史赛克(SYK)$